Indeed, in studies using DLBCL B cells, Clark and colleagues found that Core 2 O-glycans, regulated by GCNT1, were required for optimal CD45 binding of galectin-3, which upon binding dampened CD45 phosphatase activity and promoted B cell survival (56). This evidence concerns the gene GCNT1 and diffuse large B-cell lymphoma.